AstraZeneca

AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha
Fri, 11/16/12 - 10:13 am
AstraZeneca
Forxiga
diabetes
Dapagliflozin
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thu, 11/15/12 - 10:46 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Europe
SGLT2 inhibitor
Forxiga
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
diabetes
JNJ
Merck
Bristol-Myers Squibb
AstraZeneca
SGLT2 inhibitor
3 Potential Partners for Amarin
Motley Fool
Thu, 11/15/12 - 10:43 am
M&A
Amarin
AstraZeneca
Merck
Eli Lilly
Why Nektar Therapeutics' Shares Tumbled
Motley Fool
Tue, 11/13/12 - 12:09 pm
Nektar
AstraZeneca
Naloxegol
Foundation Medicine, AstraZeneca ink cancer genomics pact
Fierce Biotech
Mon, 11/12/12 - 12:32 pm
Foundation Medicine
AstraZeneca
genomics
CVS shucking more drugs from its coverage list
Fierce Pharma
Fri, 11/9/12 - 11:26 am
CVS
pharmacy benefits
Allergan
Lumigan
Androgel
Abbott Labs
Pfizer
Genotropin
Bristol-Myers Squibb
AstraZeneca
Onglyza
Amarin Still Playing the Dating Game
Motley Fool
Fri, 11/9/12 - 09:50 am
Amarin
M&A
AstraZeneca
AstraZeneca, PTSD And A Buried Seroquel Study
Pharmalot
Thu, 11/8/12 - 10:54 am
PTSD
AstraZeneca
Seroquel
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Sanofi
Novo Nordisk
MannKind
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Fri, 11/2/12 - 10:26 am
patents
Amarin
AstraZeneca
Bristol-Myers Squibb
GSK
Failed AstraZeneca Drugs Seen Holding Key to Next Viagra
Bloomberg
Wed, 10/31/12 - 10:05 am
Viagra
AstraZeneca
UK
Medical Research Council
What Will The New AstraZeneca CEO Get Paid?
Pharmalot
Tue, 10/30/12 - 11:40 am
Pharma CEOs
Pascal Soriot
AstraZeneca
executive pay
AstraZeneca Begins a New Global Study of FASLODEX® (fulvestrant) Injection in Patients with Hormone Receptor-Positive Advanced Breast Cancer
Yahoo
Mon, 10/29/12 - 12:08 pm
AstraZeneca
Faslodex
breast cancer
AstraZeneca May Not Be Immune To Patent Cliff But Dividend Is Solid
Seeking Alpha
Mon, 10/29/12 - 10:35 am
patent cliff
AstraZeneca
dividends
Pharma Drug Wars: Two Winners and One Loser
Wall Street Cheat Street
Sat, 10/27/12 - 11:39 am
Novartis
AstraZeneca
Sanofi
What's AZ's new CEO thinking? Let's parse his words
Fierce Pharma
Thu, 10/25/12 - 11:09 am
AstraZeneca
earnings
Pharma CEOs
Pascal Soriot
AstraZeneca Profit Beats Estimates; Forecast Unchanged
Bloomberg
Thu, 10/25/12 - 10:48 am
earnings
AstraZeneca
AstraZeneca may launch cash bid for Amarin, Daily Mail reports
Yahoo/Fly on the Wall
Wed, 10/24/12 - 10:59 am
AstraZeneca
M&A
Amarin

Pages